Get started
Author

Yahav Itzkovich

Observed name: Y. Itzkovich
ORCID: 0009-0007-7373-8224
Observed ORCID: 0009-0007-7373-8224
OpenAlex ID: A5034017683
Cytokine release syndrome risk model with T-cell engaging therapies
2025 · Pénélope Lafeuille, William A. Blumentals, et al. · Cytotherapy · 4
Brain metastases in clinical trial participants with KRAS-mutated advanced non-small cell lung cancer receiving docetaxel: Pooled data analysis
2024 · Jacob Aptekar, Rahul Jain, et al. · Lung Cancer · 3
PIN83 The COVID-19 Research Database: Building One of the Largest PRO Bono Real-World DATA Repositories
2021 · A. Talwai, V. Wing, et al. · Value in Health · 3
PDF
Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies
2023 · Penelope Lafeuille, William Blumentals, et al. · Blood · 1
PDF
Progression‐free survival and overall survival in the first‐line treatment of BRCA wild‐type advanced epithelial ovarian cancer: An analysis of patient‐level data pooled from historical clinical trials
2026 · Le Su, Mehmet Burcu, et al. · Cancer
PDF
Co66 Association Between Progression-free Survival and Overall Survival Among Individuals Receiving First-line Treatment for Brca Wild-type Advanced Epithelial Ovarian Cancer: a Patient-level Analysis of Pooled Historical Clinical Trials
2026 · Le Su, Lei Chen, et al. · Value in Health
PP01.78 Brain Metastasis in Patients With KRAS Mutant Advanced NSCLC Receiving Docetaxel: Pooled Clinical Trial Data Analysis
2023 · J. Aptekar, R. Jain, et al. · Journal of Thoracic Oncology
PDF
Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data
2021 · Vibhu Agarwal, Alexandru Socolov, et al. · Blood
Works count: 8
Citation count: 11
H-index: 3
I10-index:
Year
Topic
Type